SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?

The ongoing SARS-CoV-2 pandemic has led to the focused application of resources and scientific expertise toward the goal of developing investigational vaccines to prevent COVID-19. The highly collaborative global efforts by private industry, governments and non-governmental organizations have result...

Descripción completa

Detalles Bibliográficos
Autores principales: Chakraborty, Saborni, Mallajosyula, Vamsee, Tato, Cristina M., Tan, Gene S., Wang, Taia T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816567/
https://www.ncbi.nlm.nih.gov/pubmed/33482248
http://dx.doi.org/10.1016/j.addr.2021.01.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816567/
https://www.ncbi.nlm.nih.gov/pubmed/33482248
http://dx.doi.org/10.1016/j.addr.2021.01.014

Ejemplares similares